Scientists track Cancer-Fighting antibody with imaging
NCT ID NCT02307630
Summary
This study aims to understand how a lab-made antibody called Hu3F8 moves through the body and reaches tumors in patients with certain advanced cancers. Researchers will use a special PET scan to track a tiny radioactive tag attached to the antibody. The goal is to gather information that could help design future treatments, not to treat the cancer directly in this study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.